CRF-1 Antagonist and CRF-2 Agonist Decrease Binge-Like Ethanol Drinking in C57BL/6J Mice Independent of the HPA Axis

被引:0
|
作者
Emily G Lowery
Marina Spanos
Montserrat Navarro
Angela M Lyons
Clyde W Hodge
Todd E Thiele
机构
[1] University of North Carolina,Department of Psychology
[2] Bowles Center for Alcohol Studies,Department of Psychiatry
[3] University of North Carolina,Department of Pharmacology
[4] University of North Carolina,undefined
[5] University of North Carolina,undefined
来源
Neuropsychopharmacology | 2010年 / 35卷
关键词
drinking in the dark; CRF receptor; HPA axis; binge drinking; ethanol consumption; C57BL/6J mice;
D O I
暂无
中图分类号
学科分类号
摘要
Recent evidence suggests that corticotropin-releasing factor (CRF) receptor (CRFR) signaling is involved in modulating binge-like ethanol consumption in C57BL/6J mice. In this report, a series of experiments were performed to further characterize the role of CRFR signaling in binge-like ethanol consumption. The role of central CRFR signaling was assessed with intracerebroventricular (i.c.v.) infusion of the nonselective CRFR antagonist, α-helical CRF9–41 (0, 1, 5, 10 μg/1 μl). The contribution of central CRF type 2 receptor (CRF2R) signaling was assessed with i.c.v. infusion of the selective CRF2R agonist, urocortin (Ucn) 3 (0, 0.05, 0.1, or 0.5 μg/1 μl). The role of the hypothalamic–pituitary–adrenal (HPA) axis was assessed by pretreating mice with intraperitoneal (i.p.) injection of (1) the corticosterone synthesis inhibitor, metyrapone (0, 50, 100, 150 mg/kg) or (2) the glucocorticoid receptor antagonist, mifepristone (0, 25, 50 mg/kg), and (3) by using radioimmunoassay to determine whether binge-like ethanol intake influenced plasma corticosterone levels. Finally, we determined whether the ability of the CRF1R antagonist, CP-154,526 (CP; 0, 10, 15 mg/kg, i.p.), to blunt binge-like drinking required normal HPA axis signaling by comparing the effectiveness of CP in adrenalectomized (ADX) and normal mice. Results showed that i.c.v. infusion of a 1 μg dose of α-helical CRF9–41 significantly attenuated binge-like ethanol consumption relative to vehicle treatment, and i.c.v. infusion of Ucn 3 dose-dependently blunted binge-like drinking. On the other hand, metyrapone nonselectively reduced both ethanol and sucrose consumption, mifepristone did not alter ethanol drinking, and binge-like drinking did not correlate with plasma corticosterone levels. Finally, i.p. injection of CP significantly attenuated binge-like ethanol intake in both ADX and normal mice. Together, these results suggest that binge-like ethanol intake in C57BL/6J mice is modulated by CRF1R and CRF2R signaling, such that blockade of CRF1R or activation of CRF2R effectively reduces excessive ethanol intake. Furthermore, normal HPA axis signaling is not necessary to achieve binge-like drinking behavior.
引用
收藏
页码:1241 / 1252
页数:11
相关论文
共 50 条
  • [31] Corticotropin Releasing Factor Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J Mice
    Albrechet-Souza, Lucas
    Hwa, Lara S.
    Han, Xiao
    Zhang, Eric Y.
    DeBold, Joseph F.
    Miczek, Klaus A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2015, 39 (09) : 1609 - 1618
  • [32] Central Neuropeptide Y Modulates Binge-Like Ethanol Drinking in C57BL/6J Mice via Y1 and Y2 Receptors
    Sparrow, Angela M.
    Lowery-Gionta, Emily G.
    Pleil, Kristen E.
    Li, Chia
    Sprow, Gretchen M.
    Cox, Benjamin R.
    Rinker, Jennifer A.
    Jijon, Ana M.
    Pena, Jose
    Navarro, Montserrat
    Kash, Thomas L.
    Thiele, Todd E.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (06) : 1409 - 1421
  • [33] Central Neuropeptide Y Modulates Binge-Like Ethanol Drinking in C57BL/6J Mice via Y1 and Y2 Receptors
    Angela M Sparrow
    Emily G Lowery-Gionta
    Kristen E Pleil
    Chia Li
    Gretchen M Sprow
    Benjamin R Cox
    Jennifer A Rinker
    Ana M Jijon
    José Peňa
    Montserrat Navarro
    Thomas L Kash
    Todd E Thiele
    Neuropsychopharmacology, 2012, 37 : 1409 - 1421
  • [34] IL-1β IMMUNOREACTIVITY IS INCREASED IN THE AMYGDALA AND HIPPOCAMPUS OF C57BL/6J MICE WITH A HISTORY OF BINGE-LIKE ETHANOL INTAKE
    Marshall, S. A.
    Casachahua, J. D.
    Lylse, D. T.
    Thiele, T. E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 21A - 21A
  • [35] Cyfip2allelic variation in C57BL/6J and C57BL/6NJ mice alters free-choice ethanol drinking but not binge-like drinking or wheel-running activity
    Hartmann, Matthew C.
    McCulley, Walter D.
    Holbrook, Sarah E.
    Haney, Megan M.
    Smith, Caitlin G.
    Kumar, Vivek
    Rosenwasser, Alan M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 (08): : 1518 - 1529
  • [36] DID it or DIDn't it? Exploration of a failure to replicate binge-like alcohol-drinking in C57BL/6J mice
    Szumlinski, Karen K.
    Coelho, Michal A.
    Lee, Kaziya M.
    Tran, Tori
    Sern, Kimberly R.
    Bernal, Alexandria
    Kippin, Tod E.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2019, 178 : 3 - 18
  • [37] Assessment of the Effects of 6 Standard Rodent Diets on Binge-Like and Voluntary Ethanol Consumption in Male C57BL/6J Mice
    Marshall, Simon Alex
    Rinker, Jennifer A.
    Harrison, Langston K.
    Fletcher, Craig A.
    Herfel, Tina M.
    Thiele, Todd E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2015, 39 (08) : 1406 - 1416
  • [38] CHARACTERIZATION OF IMMEDIATE BINGE-LIKE BEHAVIOR IN FEMALE AND MALE C57BL/6J MICE DURING INTERMITTENT ETHANOL ACCESS
    van der Vaart, A. D.
    Harris, G. M.
    Lin, F. P.
    Miles, M. F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 : 35A - 35A
  • [39] THE NOREPINEPHRINE/DOPAMINE REUPTAKE INHIBITOR, BUPROPION, SELECTIVELY BLUNTS BINGE-LIKE ETHANOL INTAKE IN C57BL/6J MICE
    Navarro, M.
    Garbutt, J. C.
    Kampov-Polevoy, A. B.
    Thiele, T. E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 148A - 148A
  • [40] ROLE OF GABA SIGNALING IN THE LATERAL HYPOTHALAMUS OF C57BL/6J MICE IN BINGE-LIKE ETHANOL INTAKE AND FOOD CONSUMPTION
    Navarro, M.
    Lowery-Gionta, E. G.
    Pleil, K. E.
    Kash, T. L.
    Thiele, T. E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 6A - 6A